logo C4C (1).png
English
English
Spanish

  • Home

  • Commercial Therapies

    • Cellistem OA
    • Cellistem IC
    • Cellistem ER

  • Biotech Portfolio

    • ArthroPaint
    • Stellium
    • Inkure Cartilage
    • Veintis
    • Inkure 3D
    • Oxium Exo
    • Cellistem EV
    • Cellistem Hydrogel
    • Cellistem SLE

  • About Us

  • News

  • Career

  • More

    Use tab to navigate through the menu items.
    Contact
    Abstract Lines

    Three therapies to meet the highest expectations

    Cellistem®IC

    Allogeneic cell therapy based on the expansion of a subpopulation of umbilical cord tissue mesenchymal cells (UC-MSCs), with unique characteristics for the treatment of Chronic Heart Failure (HF).

    Cellistem®OA

    Allogeneic cell therapy based on the expansion of a subpopulation of umbilical cord tissue mesenchymal cells (UC-MSCs), with unique characteristics for the treatment of Osteoarthritis (OA).

    Cellistem®ER

    Regenerative endodontic procedures in mature teeth with apical lesions.